The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Transcriptional Activation by Tetracyclines in Mammalian Cells
Abstract
A transcriptional transactivator was developed that fuses the VP16 activation domain with a mutant Tet repressor from Escherichia coli. This transactivator requires certain tetracycline (Tc) derivatives for specific DNA binding. Thus, addition of doxycycline to HeLa cells that constitutively synthesized the transactivator and that contained an appropriate, stably integrated reporter unit rapidly induced gene expression more than a thousandfold. The specificity of the Tet repressor-operator-effector interaction and the pharmacological characteristics of Tc's make this regulatory system well suited for the control of gene activities in vivo, such as in transgenic animals and possibly in gene therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 1995, Gossen et al. developed the Tet-On system (Fig. 1C), a regulatory system that allows activation of gene expression by the addition - instead of removal - of dox [12].”
From Tet-On Systems For Doxycycline-inducible Gene Expression (2016) · cites this paper as [12]
In the citing paper
“This reverse-TetR (rTetR) differed at four amino acid positions from the original protein (Fig. 2).”
From Tet-On Systems For Doxycycline-inducible Gene Expression (2016) · cites this paper as [12]
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Self-citation
Flagged first, then by citations
Research works printed but not linked: 13
- 10.1016/0003-2697(87)90021-2 · DOI
- 10.1016/0003-2697(83)90418-9 · DOI
- FURTH, P.A., TEMPORAL CONTROL OF GENE-EXPRESSION IN TRANSGENIC MICE BY A TETRACYCLINE-RESPONSIVE PROMOTER, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91: 9302 (1994).
- GOSSEN, M, CONTROL OF GENE ACTIVITY IN HIGHER EUKARYOTIC CELLS BY PROKARYOTIC REGULATORY ELEMENTS, TRENDS IN BIOCHEMICAL SCIENCES 18: 471 (1993). · DOI
- HECHT, B, NONINDUCIBLE TET REPRESSOR MUTATIONS MAP FROM THE OPERATOR BINDING MOTIF TO THE C-TERMINUS, JOURNAL OF BACTERIOLOGY 175: 1206 (1993). · DOI
- HILLEN, W, MECHANISMS UNDERLYING EXPRESSION OF TN10 ENCODED TETRACYCLINE RESISTANCE, ANNUAL REVIEW OF MICROBIOLOGY 48: 345 (1994). · DOI · Paper page
- HINRICHS, W, STRUCTURE OF THE TET REPRESSOR TETRACYCLINE COMPLEX AND REGULATION OF ANTIBIOTIC-RESISTANCE, SCIENCE 264: 418 (1994). · DOI · Paper page
- MULLER G THESIS U ERLANGEN NU (1995).
- RESNITZKY, D, ACCELERATION OF THE G(1)/S PHASE-TRANSITION BY EXPRESSION OF CYCLIN-D1 AND CYCLIN-E WITH AN INDUCIBLE SYSTEM, MOLECULAR AND CELLULAR BIOLOGY 14: 1669 (1994).
- 10.1073/pnas.81.7.1991 · DOI
- SOUTHERN, P.J., J MOL APPL GENET 1: 327 (1982).
- WEINMANN, P, A CHIMERIC TRANSACTIVATOR ALLOWS TETRACYCLINE-RESPONSIVE GENE-EXPRESSION IN WHOLE PLANTS, PLANT JOURNAL 5: 559 (1994). · DOI
- YARRANTON, G.T., CURR OPIN BIOTECH 3: 506 (1992). · DOI
Cited by
Sorted by citations
Items 501–600 of 1,006
Creating small-molecule-dependent switches to modulate biological functions.
Buskirk, A. R., & Liu, D. R. (2005) · Chemistry and Biology · doi:10.1016/j.chembiol.2004.11.012 · Cited by 75
“The evolution of a reversed allosteric response in the TetR protein [20] and the engineering of ligand binding sites in a DNA binding domain [14] are examples of engineered allosteric regulation of protein function with small molecules.”
BackgroundLamartina, S., Silvi, L., Roscilli, G., Casimiro, D., Simon, A. J., Davies, M., Shiver, J., Rinaudo, C. D., Zampaglione, I., Fattori, E., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00051-5 · Cited by 75
“An alternative version of this system was subsequently generated, based on a mutant form of tTA, called reverse tTA (rtTA), which binds to tetO and activates transcription only in the presence of the ligand [7].”
MethodSelf-citationHarrington, K., Álvarez-Vallina, L., Crittenden, M., Gough, M., Chong, H., Diaz, R., Vassaux, G., Lemoine, N., & Vile, R. (2002) · Human Gene Therapy · doi:10.1089/104303402760128504 · Cited by 75
Gene therapy in wound repair and regeneration
Yao, F., & Eriksson, E. (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00443.x · Cited by 75
Gillemans, N., Tewari, R., Lindeboom, F., Rottier, R. J., de Wit, T., Wijgerde, M., Grosveld, F. G., & Philipsen, S. (1998) · Genes & Development · doi:10.1101/gad.12.18.2863 · Cited by 65
“Several binary systems for regulating gene expression have been described, for instance, the yeast GAL4/UAS, the bacterial tet-repressor/operator, and steroid-inducible systems (Ornitz et al. 1991; Gossen et al. 1995; No et al. 1996; Wang et al. 1997).”
BackgroundSynthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
Teixeira, A. P., & Fussenegger, M. (2023) · Advanced Science · doi:10.1002/advs.202309088 · Cited by 79
Robida, A. M., & Kerppola, T. K. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.069 · Cited by 82
Leneuve, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng021 · Cited by 65
“cycline-dependent transactivator (26); tetO, tetracycline resistance operon;”
Perez, N., Plence, P., Millet, V., Greuet, D., Minot, C., Noel, D., Danos, O., Jorgensen, C., & Apparailly, F. (2002) · Human Gene Therapy · doi:10.1089/104303402320987851 · Cited by 73
“The tetracycline-controlled expression systems (Gossen and Bujard, 1992; Gossen et al. , 1995) are widely used to regulate gene expression and were shown to function in different organisms (Fishman et al. , 1994; Wein-mann et al. , 1994; Kistner et al. , 1996; Gari et al. , 1997; Gi-1 rard et al. ,…”
Expression and Characterization of Recombinant Murine Factor VIII
Doering, C., Parker, E., Healey, J., Craddock, H. N., Barrow, R. T., & Lollar, P. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613237 · Cited by 73
Nebert, D. W., & Duffy, J. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00740-x · Cited by 73
Generating Conditional Mouse Mutants via Tetracycline-Controlled Gene Expression
Schönig, K., & Bujard, H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-340-2:69 · Cited by 65
Self-citationProgress and Perspectives in the Development of Lentiviral Vector Producer Cells
Ferreira, M. V., Cabral, E. T., & Coroadinha, A. S. (2020) · Biotechnology Journal · doi:10.1002/biot.202000017 · Cited by 87
Synthetic Switches and Regulatory Circuits in Plants
Andres, J., Blomeier, T., & Zurbriggen, M. D. (2019) · PLANT PHYSIOLOGY · doi:10.1104/pp.18.01362 · Cited by 82
“A reversed TetR was generated by random mutagenesis (Gossen et al., 1995), which, when fused to the VP16 domain, enables tetracycline-induced transcriptional activation (Fig.”
BackgroundRobust Synthetic Circuits for Two-Dimensional Control of Gene Expression in Yeast
Aranda-Díaz, A., Mace, K., Zuleta, I. A., Harrigan, P., & El‐Samad, H. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00251 · Cited by 62
Preinspiratory calcium rise in putative pre‐Bötzinger complex astrocytes
Okada, Y., Sasaki, T., Oku, Y., Takahashi, N., Seki, M., Ujita, S., Tanaka, K. F., Matsuki, N., & Ikegaya, Y. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.231464 · Cited by 72
“…from Karl Deisseroth (Berndt et al. 2009), was selectively expressed in astrocytes using the tetracycline transactivator (tTA)–tetO promoter strategy (Gossen et al. 1995), whereby two lines of mice were bred, one expressing an astrocyte-specific promoter driving tTA expression and the other…”
MethodAAV Vectors for Cardiac Gene Transfer: Experimental Tools and Clinical Opportunities
Pacak, C. A., & Byrne, B. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.124 · Cited by 71
Expression of Pseudomonas aeruginosa Toxin ExoS Effectively Induces Apoptosis in Host Cells
Jia, J.-H., Wang, Y., Zhou, L., & Jin, S.-G. (2006) · Infection and Immunity · doi:10.1128/iai.00591-06 · Cited by 72
“In this system, the transcription of the gene of interest is blocked in the absence of an inducer, such as tetracycline or doxycycline, but is permitted or activated after the inducer is added into culture medium (33, 94).”
BackgroundKrey, T., Himmelreich, A., Heimann, M., Menge, C., Thiel, H., Maurer, K., & Rümenapf, T. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.3912-3922.2006 · Cited by 72
“For expression of the CD46 mutants in SK6 cells the Tet-on expression system was applied ( 14 ).”
MethodConditional expression of a myocardium‐specific transgene in zebrafish transgenic lines
Huang, C.-J., Jou, T., Ho, Y., Lee, W., Jeng, Y.-T., Hsieh, F., & Tsai, H.-J. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20485 · Cited by 72
“By taking advantage of the regulatory loop of tet resistance in prokaryotes, tight control of gene expression can be accomplished by titrating the dose of Tet (Gossen and Bujard, 1992) or its more stable derivative doxycycline (Dox; Gossen et al., 1995).”
BackgroundMethodPollock, A. S., Turck, J., & Lovett, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-0602com · Cited by 72
“To evaluate the effect of more modest levels of expression of the IL-1 propiece, we engineered A375 melanoma cells to express the tet trans-activator (12).”
BackgroundMethodInfluentialRizzu, P., Joosse, M., Ravid, R., Hoogeveen, A., Kamphorst, W., van Swieten, J. V., Willemsen, R., & Heutink, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3075 · Cited by 72
“PC12 cells were stably transfected with the wild-type and P301L tau cloned in pTRE vectors using the Tet-On Gene expression system (Clontech) (37).”
Heintz, N. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.937 · Cited by 72
Using genetically incorporated unnatural amino acids to control protein functions in mammalian cells
Nödling, A. R., Spear, L. A., Williams, T. L., Luk, L. Y. P., & Tsai, Y. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180042 · Cited by 112
Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers
Aiderus, A., Black, M. A., & Dunbier, A. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4626-9 · Cited by 80
Shitashige, M., Naishiro, Y., Idogawa, M., Honda, K., Ono, M., Hirohashi, S., & Yamada, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.007 · Cited by 71
Regulation of CD4 Expression via Recycling by HRES-1/RAB4 Controls Susceptibility to HIV Infection
Nagy, G., Ward, J. P., Mosser, D. D., Koncz, Á., Gergely, P., Stancato, C., Qian, Y., Fernández, D., Niland, B. P., Grossman, C. E., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606301200 · Cited by 89
Stuhlmann-Laeisz, C. M., Lang, S., Chalaris, A., Paliga, K., Sudarman, E., Eichler, J., Klingmüller, U., Samuel, M. S., Ernst, M., Rose‐John, S., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1129 · Cited by 72
“pression system (Gossen et al., 1995), may provide an excit-”
BackgroundWong, E.-T., Kolman, J., Li, Y.-C., Mesner, L., Hillen, W., Berens, C., & Wahl, G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni145 · Cited by 71
“for gene therapy and in transgenic animals) (7,9).”
BackgroundSelf-citationChenuaud, P., Larcher, T., Rabinowitz, J. E., Provost, N., Joussemet, B., Bujard, H., Samulski, R. J., Moullier, P., & Favre, D. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.12.015 · Cited by 74
“A tetR mutant exhibits a reverse phenotype requiring Dox for binding to the tetO operator [12].”
BackgroundSelf-citationVlcek, S., Just, H., Dechat, T., & Foisner, R. (1999) · doi:10.1093/emboj/18.22.6370 · Cited by 71
“The Tet-On response plasmid pCM108, a derivative of pUHD10-3 (Gossen and Bujard, 1995; Gossen et al., 1995) that contains a Myc-tag”
BackgroundMethodEncoding of odor fear memories in the mouse olfactory cortex
Meissner-Bernard, C., Dembitskaya, Y., Venance, L., & Fleischmann, A. (2018) · bioRxiv · doi:10.1101/297226 · Cited by 70
“Temporal control of DREADD expression is provided by doxycycline, administered through the diet, which interferes with the binding of tTA to tetO and thus suppresses transgene expression (Gossen et al., 1995).”
Wang, I., Zhang, Y., Snyder, J. E., Sutherland, M. J., Burhans, M. S., Shannon, J. M., Park, H. J., Whitsett, J. A., & Kalinichenko, V. V. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.08.027 · Cited by 70
“GFP-FoxM1b N-terminal deletion mutant (GFP-FoxM1-ΔN) was subcloned into a plasmid containing minimal CMV promoter with a tetracycline operator (TetO7-CMV), and the 3′-untranslated region of the bovine growth hormone (bGH) gene polyadenylation (polyA) signal (Clark et al., 2001; Gossen et al., 1995) (Fig.”
BackgroundMethodImpaired neural development caused by inducible expression of Axin in transgenic mice
Yu, H. I., Liu, B., Costantini, F. D., & Hsu, W. (2006) · Mechanisms of Development · doi:10.1016/j.mod.2006.10.002 · Cited by 60
“Using the tet-on system (Gossen et al., 1995; Urlinger et al., 2000), we developed a series of mouse strains that permits conditional gene expression in the Axin2-expressing cells.”
MethodTanabe, K., Takahashi, Y., Sato, Y., Kawakami, K., Takeichi, M., & Nakagawa, S. (2006) · Development · doi:10.1242/dev.02566 · Cited by 64
“To induce exogenous gene expression in a stage-specific manner, we employed the tetracycline-mediated conditional gene expression system (Gossen et al., 1995).”
MethodMouse models for multistep tumorigenesis.
Wu, X.-M., & Pandolfi, P. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02127-4 · Cited by 70
“50 Gossen, M. et al. (1995) Transcriptional activation by tetracyclines in”
BackgroundBlidner, R. A., Svoboda, K., Hammer, R. P., & Monroe, W. T. (2008) · Molecular Biosystems · doi:10.1039/b801532e · Cited by 69
Expression of Transgenes Targeted to the Gt(ROSA)26Sor Locus Is Orientation Dependent
Strathdee, D., Ibbotson, H. C., & Grant, S. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000004 · Cited by 69
“Random mutagenesis of TetR generated a new transactivator (rtTA), which binds and transactivates gene expression in the presence of doxycycline (dox) [5].”
Vuillemenot, B. R., Rodriguez, J. F., & Hoyle, G. W. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0062oc · Cited by 69
“The rtTA ( 13 ) is expressed from the lungspecific SPC promoter (4, 14).”
BackgroundMethodVenditti, M., Iwasiow, B. M., Orr, F. W., & Shiu, R. P. C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10269 · Cited by 69
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse
Chang, S. S., Khoo, C., & DePinho, R. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0374 · Cited by 64
Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system.
Watsuji, T., Okamoto, Y., Emi, N., Katsuoka, Y., & Hagiwara, M. (1997) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1997.6705 · Cited by 69
Use of HIV as a gene transfer vector.
Pluta, K. D., & Kacprzak, M. M. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2490 · Cited by 76
“This response does not exhibit a threshold characteristic and is dose-dependent (Gossen & Bujard, 1992; Gossen et al., 1995; Kringstein et al., 1998).”
BackgroundPathak, G. P., Spiltoir, J. I., Höglund, C., Polstein, L. R., Heine-Koskinen, S., Gersbach, C., Rossi, J., & Tucker, C. L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx260 · Cited by 68
“Chemically-regulated systems such as Tet-OFF and Tet-ON, which allow blockage or induction of transcriptional activity with the addition of a small molecule, have been widely used for inducible regulation (1,2).”
MethodSingh, V. K., Gupta, D., & Arora, R. (2015) · Discoveries · doi:10.15190/d.2015.27 · Cited by 79
“J Biol Chem 2003, 278(26): 24233-24241.”
Kirchner, F., Schuetz, A., Boldt, L., Martens, K., Dittmar, G., Haverkamp, W., Thierfelder, L., Heinemann, U., & Gerull, B. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961854 · Cited by 68
Adriaansen, J., Vervoordeldonk, M. J., & Tak, P. P. (2006) · Rheumatology · doi:10.1093/rheumatology/kel047 · Cited by 68
“Viral IL-10 was successfully delivered to muscle using a Tet-on promoter in a rAAV2 vector in murine CIA [23].”
Inducible and neuron‐specific gene expression in the adult mouse brain with the rtTA2S‐M2 system
Michalon, A., Koshibu, K., Baumgärtel, K., Spirig, D. H., & Mansuy, I. (2005) · Genesis · doi:10.1002/gene.20175 · Cited by 68
“It is constitutively silent but needs dox to bind tetO sequences and induce gene transcription (Gossen et al., 1995; Orth et al., 2000).”
BackgroundIn vivo transposition of Minos, a Drosophila mobile element, in mammalian tissues
Zagoraiou, L., Drabek, D., Alexaki, S., Guy, J. A., Klinakis, A. G., Langeveld, A., Skavdis, G., Mamalaki, C., Grosveld, F., & Savakis, C. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.201392398 · Cited by 68
Tumor necrosis factor‐a and the progression of diabetes in non‐obese diabetic mice
Green, E. A., & Flavell, R. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01302.x · Cited by 68
Tang, Y., Clayburgh, D. R., Mittal, N., Goretsky, T., Dirisina, R., Zhang, Z., Kron, M. M., Ivancic, D., Katzman, R. B., Grimm, G. R., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090548 · Cited by 74
Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders
Keck, M. E., Ohl, F., Holsboer, F., & Müller, M. B. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.003 · Cited by 64
Hong, H., Chong, J. L., Song, W., Song, E. J., Jyawook, A. A., Schook, A. C., Ko, C. H., & Takahashi, J. S. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0030033 · Cited by 59
“The tTA system was originally developed by Bujard and colleagues for the conditional expression of reporter genes in mammalian cells [31–34] and has been successfully applied in many experiments to study a variety of developmental processes and brain function in mammals [35–45].”
BackgroundLackner, T., Müller, A., König, M., Thiel, H., & Tautz, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9746-9755.2005 · Cited by 67
“tein of the Tet-on system (10), was established as described previously for cell”
MethodRegulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons.
Blesch, A., Conner, J., Pfeifer, A., Gasmi, M., Ramirez, A., Britton, W. R., Alfa, R. W., Verma, I., & Tuszynski, M. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.007 · Cited by 67
HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation.
Cho, J.-W., Baek, W.-K., Yang, S.-H., Chang, J., Sung, Y., & Suh, M. (2001) · Biochimica et Biophysica Acta · doi:10.1016/s0167-4889(00)00137-3 · Cited by 67
Inducible regulation of Runx2-stimulated osteogenesis
Gersbach, C., le Doux, J. M., Guldberg, R., & García, A. J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302725 · Cited by 67
Kelley, C. P., Haerle, M. C., & Wang, E. T. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111226 · Cited by 61
A tetracycline- inducible and skeletal muscle specific Cre recombinase transgenic mouse
Rao, P.-C., & Monks, D. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20714 · Cited by 66
“TRE can effectively drive gene expression in mammalian cells when used in conjunction with the minimal human cytomegalovirus (CMV) promoter (Gossen et al., 1995).”
Specific Knockdown of OCT4 in Human Embryonic Stem Cells by Inducible Short Hairpin RNA Interference
Zafarana, G., Avery, S., Avery, K., Moore, H., & Andrews, P. (2009) · Stem Cells · doi:10.1002/stem.5 · Cited by 66
Tang, Q., Zhang, D.-S., Cong, X.-M., Wan, M.-L., & Jin, L.-Q. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.038 · Cited by 66
Schwarzmann, N., Kunerth, S., Weber, K., Mayr, G., & Guse, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209061200 · Cited by 66
Smith, R. C., Machluf, M., Bromley, P. A., Atala, A., & Walsh, K. X. (2002) · Human Gene Therapy · doi:10.1089/104303402317322267 · Cited by 64
“…(Walther and Stein, 1996) and synthetic (Nettelbeck et al ., 2000) tissue-specific promoters, to confer local expression, and pharmacologically regulat-able promoters that are induced by small molecule effectors such as tetracycline (Gossen et al ., 1995) or rapamycin (Rivera et al ., 1996).”
Blesch, A., Conner, J. M., & Tuszynski, M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301480 · Cited by 66
Schaufele, F., Chang, C., Liu, W., Baxter, J. D., Nordeen, S. K., Wan, Y., Day, R. N., & McDonnell, D. P. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0572 · Cited by 62
“2 mg), which expresses the tetracycline repressor/VP16 activator (49) used to regulate expression of the pTRE plasmid, was cotransfected with the pTRE-GFP-LXXLL or pTREGFP-a/bV expression vectors.”
MethodHighly Conserved RNA Sequences That Are Sensors of Environmental Stress
Spicher, A., Guicherit, O. M., Duret, L., Aslanian, A., Sanjines, E. M., Denko, N. C., Giaccia, A. J., & Blau, H. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7371 · Cited by 60
Transgenic analysis of thymocyte signal transduction
Cantrell, D. (2002) · Nature reviews. Immunology · doi:10.1038/nri703 · Cited by 66
“One key development is the generation of inducible expression systems based on tetracycline-regulated gene promoter”
Inducible control of gene expression: prospects for gene therapy.
Harvey, D., & Caskey, C. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80128-2 · Cited by 66
Romanova, N., & Noll, T. (2017) · Biotechnology Journal · doi:10.1002/biot.201700232 · Cited by 70
Engineering of Synthetic Mammalian Gene Networks
Weber, W., & Fussenegger, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.005 · Cited by 66
“, 2000) or reverse the DNA-binding characteristics in the presence of a specific inducer (Gossen et al., 1995).”
BackgroundMemory and behavior: a second generation of genetically modified mice.
Mayford, M., Mansuy, I., Muller, R., & Kandel, E. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00287-9 · Cited by 65
“Also, Bujard’s group [45] has generated a mutant of the tTA molecule that displays a reversed response to doxycycline.”
BackgroundKramm, C. M., Sena‐Esteves, M., Barnett, F. H., Rainov, N. G., Schuback, D. E., Yu, J. S., Pechan, P. A., Paulus, W., Chiocca, E. A., & Breakefield, X. O. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00615.x · Cited by 103
Recent advances in gene mutagenesis by site-directed recombination.
Marth, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118634 · Cited by 64
Hojman, P., Gissel, H., & Gehl, J. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302951 · Cited by 64
Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS
Johansen, J., Rosenblad, C., Andsberg, K., Møller, A., Lundberg, C., Björlund, A., & Johansen, T. E. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301778 · Cited by 64
Cell replacement therapy for type 1 diabetes.
Efrat, S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02365-1 · Cited by 64
Tetracyclines inhibit activated B cell function.
Kuzin, I., Snyder, J. E., Ugine, G. D., Wu, D., Lee, S., Bushnell, T., Insel, R., Young, F. M., & Bottaro, A. (2001) · International Immunology · doi:10.1093/intimm/13.7.921 · Cited by 64
Development of optimized vectors for gene therapy.
Nabel, G. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.2.324 · Cited by 64
Beyond 'knock-out' mice: new perspectives for the programmed modification of the mammalian genome.
Cohen-Tannoudji, M., & Babinet, C. (1998) · Molecular human reproduction · doi:10.1093/molehr/4.10.929 · Cited by 64
“One of these systems was devised by Gossen et al. (1995) (reviewed in Shockett and Schatz, 1996).”
BackgroundMolin, M., Shoshan, M., Öhman-Forslund, K., Linder, S., & Akusjärvi, G. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8358-8361.1998 · Cited by 64
“Transcription of the CAT reporter gene is activated by the addition of doxycycline (DOX) to the culture medium (4).”
BackgroundMethodMammalian synthetic biology: emerging medical applications
Kis, Z., Pereira, H. S., Homma, T., Pedrigi, R. M., & Krams, R. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1000 · Cited by 68
“A reverse tetracycline-controlled transactivator rtTA has also been created by point mutating the tTA gene [57,92].”
BackgroundCD 19 chimeric antigen receptor T cell therapy for haematological malignancies
Ghorashian, S., Pulè, M. A., & Amrolia, P. J. (2015) · British Journal of Haematology · doi:10.1111/bjh.13340 · Cited by 62
“While druginducible transgene expression systems have been extensively used in vitro, this technology is not easily translatable as it often relies on xenogeneic transcriptional activators e.g. in the tetracycline-regulated (Tet) gene expression systems (Gossen et al, 1995).”
BackgroundTemporal Control of Cell-Specific Transgene Expression in Caenorhabditis elegans
Bacaj, T., & Shaham, S. (2007) · Genetics · doi:10.1534/genetics.107.074369 · Cited by 63
Zhou, B., Ye, Z.-H., Chen, G.-B., Gao, Z., Zhang, Y., & Cheng, L.-Z. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0128 · Cited by 63
Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis
Tran, S. E. F., Meinander, A., Holmström, T., Rivero-Müller, A., Heiskanen, K., Linnau, E. K., Courtney, M., Mosser, D., Sistonen, L., & Eriksson, J. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401278 · Cited by 63
“A Jurkat cell line expressing the reverse tetracycline-controlled transactivator (rtTA) was generated by electroporation-mediated transfection with the plasmid pUHD17201neo.(66) A Jurkat-rtTA clone was then transfected with the tetracycline-regulated dicistronic Hsp70/GFP expression plasmid pTR5DC/Hsp70-GFP*tk/hygro.”
MethodSerguera, C., Bohl, D., Rolland, E., Prevost, P., & Heard, J. (1999) · Human Gene Therapy · doi:10.1089/10430349950018823 · Cited by 63
Kojima, H., Abiru, Y., Sakajiri, K., Watabe, K., Ohishi, N., Takamori, M., Hatanaka, H., & Yagi, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7183 · Cited by 63
Versatile Retrovirus Vector Systems for Regulated Gene Expression In Vitro and In Vivo
Lindemann, D., Patriquin, E., Feng, S., & Mulligan, R. (1997) · Molecular Medicine · doi:10.1007/bf03401693 · Cited by 63
Temporal variation in estrogen receptor-α protein turnover in the presence of estrogen
Valley, C. C., Solodin, N. M., Powers, G. L., Ellison, S. J., & Alarid, E. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0067 · Cited by 63
“Briefly, S118E-ERHA was subcloned into the pUHD10-3 vector Journal of Molecular Endocrinology (2008) 40, 23–34 (Gossen et al. 1995) downstream of the tet-resistance operator.”
BackgroundMethodMurine Models of Acute Myeloid Leukaemia
Almosailleakh, M., & Schwaller, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020453 · Cited by 74
“The Tet system can be designed to inhibit (Tet-off) or induce (Tet-on) the expression of a transgene, by either coupling it with a Tet-sensitive transcriptional repressor (tTA) or a reverse-tTA (rtTA) transcriptional activator respectively [79].”
BackgroundMcIsaac, R. S., Silverman, S., McClean, M., Gibney, P., Macinskas, J., Hickman, M. J., Petti, A., & Botstein, D. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-05-0466 · Cited by 62
“A met4 null allele has a growth defect and produces small colonies on YPD plates (Hickman et al., 2011).”
Huettner, C. S., Koschmieder, S., Iwasaki, H., Iwasaki-Arai, J., Radomska, H. S., Akashi, K., & Tenen, D. G. (2003) · Blood · doi:10.1182/blood-2003-03-0768 · Cited by 65
Bone Morphogenetic Protein Gene Therapy
Alden, T., Várady, P., Kallmes, D. F., Jane, J., & Helm, G. (2002) · Spine · doi:10.1097/00007632-200208151-00016 · Cited by 62
“This may be possible by the use of inducible promoters, which allow for the exogenous regulation of transgene expression using nontoxic, inert agents.(43,63) The most commonly used system is tetracycline based.”
BackgroundFotsis, T., Breit, S., Lutz, W., Rössler, J., Hatzi, E., Schwab, M., & Schweigerer, L. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00575.x · Cited by 62
“3 molecules, and eliminate any possibility that this regulation was caused from additional genetic changes of long-term culture, we have used an inducible eukaryotic expression system based on the tetracycline repressor of Escherichia coli [21,22].”
MethodUse of tetracycline-controlled gene expression systems to study mammalian cell cycle.
Freundlieb, S., Baron, U., Bonin, A. L., Gossen, M., & Bujard, H. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)83014-5 · Cited by 62
Self-citationSmart-watch-programmed green-light-operated percutaneous control of therapeutic transgenes
Mansouri, M., Hussherr, M., Strittmatter, T., Buchmann, P., Xue, S., Camenisch, G., & Fussenegger, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23572-4 · Cited by 71
Genetically manipulated mouse models of lung disease: potential and pitfalls
Baron, R. M., Choi, A. J. S., Owen, C. A., & Choi, A. M. K. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00085.2011 · Cited by 64
“A “tet-on” system has been developed through engineering the reverse tetracycline transcriptional activator (rtTA) that binds tetO and activates gene transcription only in the presence of doxycycline (59, 105).”
BackgroundGillis, P., Okagaki, L. H., & Rice, S. (2008) · Journal of Virology · doi:10.1128/jvi.01944-08 · Cited by 61
“We then transfected G418-resistant HTO cells, which are HeLa cells stably expressing the Tet-on transactivator ( 20 ), with pTE27 and a linear hygromycin resistance gene.”
BackgroundMethodInfluentialMatthess, Y., Kappel, S., Spänkuch, B., Zimmer, B., Kaufmann, M., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208472 · Cited by 61
“We examined the dose–response for Dox, a Tet derivative, which was previously shown to be a very efficient effector for TetR (Gossen et al., 1995).”
MethodDemonstration of site-directed recombination in transgenic zebrafish using the Cre/loxP system
Pan, X., Wan, H., Chia, W., Tong, Y., & Gong, Z. (2005) · Transgenic research · doi:10.1007/s11248-004-5790-z · Cited by 61
Metadata
- Authors
- Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H.
- Affiliations
- Heidelberg University (DE)
- ORCID
- Gossen, Manfred
- Venue
- Science
- Published
- 1995-06-23
- Volume
- 268
- Issue
- 5218
- Pages
- 1766-1769
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2005275397
- Cited by
- 2,488
- References
- 0
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 45 · 2023: 49 · 2022: 55 · 2021: 60 · 2020: 68 · 2019: 52 · 2018: 55 · 2017: 47 · 2016: 52 · 2015: 62 · 2014: 53 · 2013: 67 · 2012: 64
- FWCI
- 48.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- tetracycline, transcriptional activation, Tet repressor, VP16 activation domain, doxycycline, gene expression regulation, transcriptional activator, transgenic animals, gene therapy
- MeSH terms
- Amino Acid Sequence, Doxycycline, HeLa Cells, Humans, Molecular Sequence Data, Operator Regions, Genetic, Recombinant Fusion Proteins, Repressor Proteins, Transfection, Viral Proteins, Transcriptional Activation, Trans-Activators, Genes, Reporter, Simplexvirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review